Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis

Study ID: NCT06733519
Start Date: 2026-06-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Nalmefene

Placebo

Sponsor

Tarimmane Inc

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Study ID: NCT07222800
Start Date: 2025-12-12
End Date: 2031-08-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

800

Intervention / Treatment

PF-08634404

bevacizumab

Chemotherapy

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Study ID: NCT07218692
Start Date: 2026-08-11
End Date: 2027-08-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Sturlimogen Erparepvec

Quietly

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Study ID: NCT07155200
Start Date: 2025-12-31
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

42

Intervention / Treatment

Cirtuvivint

Irinotecan

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

HIV Testing in Community Health Center Dental Clinics

Study ID: NCT07089849
Start Date: 2026-09
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6715

Intervention / Treatment

Rapid HIV testing

Referral for HIV testing

Sponsor

Boston University

Source: clinicaltrials.gov

Share:
Add to list

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

Study ID: NCT07042438
Start Date: 2026-01-17
End Date: 2028-04-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

56

Intervention / Treatment

Axicabtagene Ciloleucel

Biospecimen Collection

Chemotherapy

Fecal Microbiota Transplantation

Leukapheresis

Placebo Administration

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Advanced Fibrosis Detection for MASLD in Primary Care

Study ID: NCT07159386
Start Date: 2025-12
End Date: 2030-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

225

Intervention / Treatment

EHR alert

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver

Study ID: NCT07133854
Start Date: 2026-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Imaging PET/MRI

Stable isotope infusions

meal test

Indirect calorimetry

Sponsor

University of Sherbrooke

Source: clinicaltrials.gov

Share:
Add to list

GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer

Study ID: NCT07017829
Start Date: 2025-12-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

Anti-CFH Monoclonal Antibody GT103

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

Pembrolizumab

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass

Study ID: NCT06861881
Start Date: 2025-12
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Dexcom G7 Continuous Glucose Monitor

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list